miR-122 decreases HCV entry into hepatocytes through binding to the 3′ UTR of OCLN mRNA

Liver International

Volumn 35, Issue 4, 2015, Pages 1315-1323

  Sendi, Hossein ^a,b   Mehrab Mohseni, Marjan ^a   Foureau, David M ^a   Ghosh, Sriparna ^a   Walling, Tracy L ^a   Steuerwald, Nury ^a   Zamor, Philippe J ^a   Kaplan, Keith J ^a   Jacobs, Carl ^a   Ahrens, William A ^a   Russo, Mark W ^a   Clemens, Mark G ^b   Schrum, Laura W ^a,b   Bonkovsky, Herbert L ^a,b  

^a CAROLINAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

Author keywords

Hepatitis; Hepatitis C; Liver; Micro RNA; Occludin

Indexed keywords

CLAUDIN; LUCIFERASE; MESSENGER RNA; MICRORNA; MICRORNA 122; OCCLUDIN; 3' UNTRANSLATED REGION; MIRN122 MICRORNA, HUMAN; OCLN PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION SYSTEM; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LIVER CELL; NONHUMAN; PROTEIN EXPRESSION; VIRUS ENTRY; VIRUS PARTICLE; ANIMAL; BINDING SITE; CELL LINE; CHRONIC HEPATITIS C; COMPUTER SIMULATION; GENETIC DATABASE; GENETICS; HEPACIVIRUS; HOST PATHOGEN INTERACTION; METABOLISM; PATHOGENICITY; UPREGULATION; VIROLOGY;

3' UNTRANSLATED REGIONS; ANIMALS; BINDING SITES; CELL LINE; CLAUDINS; COMPUTER SIMULATION; DATABASES, GENETIC; DOWN-REGULATION; HEPACIVIRUS; HEPATITIS C, CHRONIC; HEPATOCYTES; HOST-PATHOGEN INTERACTIONS; HUMANS; MICRORNAS; OCCLUDIN; RNA, MESSENGER; TRANSFECTION; UP-REGULATION; VIRUS INTERNALIZATION;

EID: 84924503116     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12698     Document Type: Article

References (25)

1. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-97.
2. Chang J, Nicolas E, Marks D, et al. miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol 2004; 1: 106-13.
3. Krützfeldt J, Rajewsky N, Braich R, et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005; 438: 685-9.
4. Esau C, Davis S, Murray SF, et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 2006; 3: 87-98.
5. Elmén J, Lindow M, Schütz S, et al. LNA-mediated microRNA silencing in non-human primates. Nature 2008; 452: 896-9.
6. Elmén J, Lindow M, Silahtaroglu A, et al. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res 2008; 36: 1153-62.
7. Jopling CL, Yi M, Lancaster AM, et al. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 2005; 309: 1577-81.
8. Jopling CL. Regulation of hepatitis C virus by microRNA-122. Biochem Soc Trans 2008; 36: 1220-3.
9. Pedersen IM, Cheng G, Wieland S, et al. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 2007; 449: 919-22.
10. Lanford RE, Hildebrandt-Eriksen ES, Petri A, et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010; 327: 198-201.
11. Lindenbach BD, Evans MJ, Syder AJ, et al. Complete replication of hepatitis C virus in cell culture. Science 2005; 309: 623-6.
12. Wakita T, Pietschmann T, Kato T, et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005; 11: 791-6.
13. Evans MJ, von Hahn T, Tscherne DM, et al. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 2007; 446: 801-5.
14. Ploss A, Evans MJ, Gaysinskaya VA, et al. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 2009; 457: 882-6.
15. Pietschmann T. Virology: final entry key for hepatitis C. Nature 2009; 457: 797-8.
16. Sendi H. Dual role of miR-122 in molecular pathogenesis of viral hepatitis. Hepat Mon 2012; 12: 312-4.
17. Jangra RK, Yi M, Lemon SM. Regulation of hepatitis C virus translation and infectious virus production by the microRNA miR-122. J Virol 2010; 84: 6615-25.
18. Shimakami T, Yamane D, Jangra RK, et al. Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex. Proc Natl Acad Sci U S A 2012; 109: 941-6.
19. Shan Y, Zheng J, Lambrecht RW, et al. Reciprocal effects of micro-RNA-122 on expression of heme oxygenase-1 and hepatitis C virus genes in human hepatocytes. Gastroenterology 2007; 133: 1166-74.
20. Coulouarn C, Factor VM, Andersen JB, et al. Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene 2009; 28: 3526-36.
21. Xu J, Zhu X, Wu L, et al. MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/beta-catenin pathway. Liver Int 2012; 32: 752-60.
22. Fan CG, Wang CM, Tian C, et al. miR-122 inhibits viral replication and cell proliferation in hepatitis B virusrelated hepatocellular carcinoma and targets NDRG3. Oncol Rep 2011; 26: 1281-6.
23. Tsai WC, Hsu SD, Hsu CS, et al. MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J Clin Invest. 2012; 122: 2884-97.
24. Hsu SH, Wang B, Kota J, et al. Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. J Clin Invest 2012; 1: 2871-83.
25. Wang S, Qiu L, Yan X, et al. Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G(1) -modulated P53 activity. Hepatology 2012; 55: 730-41.